Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyan Liu

Showing results (951-960 of 965) with videos related to

Pageof 97
Sort By:
Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.
Emerging Microbes & Infections|January 20, 2022
B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responsesKe Lin, Yawen Zhou, Jingwen Ai, et al.
Heliyon|July 1, 2024
Alterations of pathogen transmission patterns and attenuated immune stimulation might be the cause of increased adult respiratory infections cases in 2023, results from a multi-center study in mainland ChinaJingwen Ai, Hongyu Wang, Haocheng Zhang, et al.
Lancet (London, England)|June 29, 2019
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017Maigeng Zhou, Haidong Wang, Xinying Zeng, et al.
Nature Communications|February 28, 2023
Unintended consequences of combating desertification in ChinaXunming Wang, Quansheng Ge, Xin Geng, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2025
Strategies reimagined: SDG-driven solutions for combating global desertificationXunming Wang, Xin Geng, Fubao Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Research Square|August 26, 2024
Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia OutcomesDavid Teachey, Haley Newman, Shawn Lee, et al.
Pageof 97

Showing results (951-960 of 965) with videos related to

Sort By:
Pageof 97
Blood Advances|February 22, 2024
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemiaRegina M Myers, Kaitlin Devine, Yimei Li, et al.
Emerging Microbes & Infections|January 20, 2022
B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responsesKe Lin, Yawen Zhou, Jingwen Ai, et al.
Heliyon|July 1, 2024
Alterations of pathogen transmission patterns and attenuated immune stimulation might be the cause of increased adult respiratory infections cases in 2023, results from a multi-center study in mainland ChinaJingwen Ai, Hongyu Wang, Haocheng Zhang, et al.
Lancet (London, England)|June 29, 2019
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017Maigeng Zhou, Haidong Wang, Xinying Zeng, et al.
Nature Communications|February 28, 2023
Unintended consequences of combating desertification in ChinaXunming Wang, Quansheng Ge, Xin Geng, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2025
Strategies reimagined: SDG-driven solutions for combating global desertificationXunming Wang, Xin Geng, Fubao Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Research Square|August 26, 2024
Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia OutcomesDavid Teachey, Haley Newman, Shawn Lee, et al.
Pageof 97